Finance

Lists
DMAC:NASDAQ
DiaMedica Therapeutics Inc
$8.23
-1.44%
(-0.12) 1D
$8.23
0.00% (0.00)
After hours
Closed: Oct 2, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DMAC...
Open
$8.49
High
$8.61
Low
$8.02
Mkt. cap
443.81M
Avg. vol.
177.77K
Volume
335.68K
52-wk high
$10.42
52-wk low
$5.24
EPS
-$0.72
Beta
0.92
Shares outstanding
53.93M
No. of employees
35
Open
$8.49
High
$8.61
Low
$8.02
Mkt. cap
443.81M
Avg. vol.
177.77K
Volume
335.68K
52-wk high
$10.42
52-wk low
$5.24
EPS
-$0.72
Beta
0.92
Shares outstanding
53.93M
No. of employees
35
News stories
From web sources and news partners
About DiaMedica Therapeutics Inc
CEO-
Employees35
Founded2000
HeadquartersMinneapolis, Minnesota, United States
SectorBiotechnology
Websitediamedica.com
Analyst ratings
Based on 1 analyst giving stock ratings to DMAC in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for DMAC in the last 3 months
Highest
Current $8.23
$12.00 (+45.81%)
Average
$12.00 (+45.81%)
Lowest
$12.00 (+45.81%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Caufield
H.C. Wainwright
Buy
Maintained
$12.00
+45.8%
09/21/2026
Chase Knickerbocker
Craig-Hallum
Buy
Maintained
-
-
06/24/2026
Thomas Flaten
Lake Street
Buy
Reiterated
$14.00
+70.1%
06/23/2026
Eric Martinuzzi
Lake Street
Buy
Maintained
$14.00
+70.1%
05/08/2026
Ben Haynor
Lake Street
Buy
Maintained
$14.00
+70.1%
04/01/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Maintained
$25.00
+203.8%
01/21/2026
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
6.44M
6.70M
7.99M
8.15M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.60M
2.51M
2.50M
2.34M
Operating expense
9.03M
9.21M
10.48M
10.50M
Total operating expenses
9.03M
9.21M
10.48M
10.50M
Operating income
-9.03M
-9.21M
-10.48M
-10.50M
Other non operating income
419.00K
-1.18M
-
-
EBT including unusual items
-8.61M
-8.73M
-10.04M
-10.13M
EBT excluding unusual items
-8.61M
-8.73M
-10.04M
-10.13M
Income tax expense
6.00K
10.00K
7.00K
7.00K
Effective tax rate
-0.07%
-0.11%
-0.07%
-0.07%
Other operating expenses
-
-
-
-
Net income
-8.62M
-8.74M
-10.04M
-10.14M
Net profit margin
-
-
-
-
Earnings per share
-0.17
-0.17
-0.19
-0.19
Interest and investment income
-
1.66M
447.00K
366.00K
Interest expense
-
-
-
-
Net interest expenses
-
1.66M
447.00K
366.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-9.02M
-9.20M
-10.47M
-10.49M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps